Huaheng Biotech: is planning to issue overseas shares and list on the Hong Kong Stock Exchange.

Huaheng Biology announced that the company is planning to issue overseas shares and list on the Hong Kong Stock Exchange. This move aims to further advance the company's globalization development strategy, enhance brand influence and core competitiveness, optimize capital structure, expand diversified financing channels, and comprehensively improve corporate governance and overall strength. Details are still pending, and this H-share listing will not result in any changes to the company's controlling shareholders and ultimate controlling persons.